Newswise — Yale Cancer Center (YCC) researchers at Yale School of Medicine will present new research at the 66th annual American Society of Hematology (ASH) annual meeting in San Diego, Calif., December 7-10.
Known as “the premier event in classical and malignant hematology”, the ASH meeting includes oral and poster presentations, as well as workshops and educational sessions for hematology professionals and advocates. Leading YCC hematologist-oncologists will share advances in treating blood cancers and blood disorders. YCC research will cover treatment disparities among older people with acute myeloid leukemia (AML), screening for psychiatric disorders in sickle cell disease, and the benefits and costs of a targeted antibody treatment for lymphoma. Presentations include:
Saturday, December 7
Presenter: Justine Ryu, MD
Presenters: Noffar Bar, Iris Isufi, MD
Screening for Cognitive Impairment and Depression in Sickle Cell Disease: How Are We Doing?
Presenters: Jennifer A. Afranie-Sakyi, Modupe Karimi, Janis Bozzo, Joanna Cole, Layla Van Doren, MD, Cece Calhoun, MD
Sunday, December 8
Speaker: Rory Shallis, MD
Leveraging Quality Metrics to Maintain Support of Your Sickle Cell Disease Center
Presenter: Cece Calhoun, MD
Presenter: Amer Zeidan, MBBS
Presenters: Amer Zeidan, MBBS, Scott Huntington, MD
Monday, December 9
Speaker: George Goshua, MD
Presenter: Scott Huntington, MD
For a full list of YCC presentations at the ASH annual meeting, click here.
Yale Cancer Center combines a tradition of innovative cancer treatment and quality care for our patients. A National Cancer Institute (NCI) designated comprehensive cancer center since 1974, Yale Cancer Center is one of only 57 such centers in the nation and the only one in Connecticut. Yale Cancer Center members include national and internationally renowned scientists and physicians at Yale School of Medicine and Smilow Cancer Hospital. This partnership enables the Center to provide the best approaches for prevention, detection, diagnosis, and treatment for cancer.
Meeting Link: 66th annual American Society of Hematology (ASH) annual meeting
MEDIA CONTACT
Register for reporter access to contact detailsRELATED EXPERTS
Amer Zeidan
Associate Professor of Internal Medicine (Hematology); Director, Early Therapeutics Research, Hematology; Leader, Clinical Research Team for Leukemias and Myeloid Malignancies, Yale Cancer Center; Chair, Protocol Review Committee (PRC) I, Yale Cancer Center; Assistant Medical Director, Clinical Trials Office (CTO), Yale Cancer Center; Director, Hematology Research Seminar Series, Hematology; Member, Executive Committee, Yale Cancer Center; Member, Clinical Trials Advisory Committee (CTAC), Yale
Yale Cancer Center/Smilow Cancer HospitalGeorge Goshua
Assistant Professor of Medicine (Hematology); Classical, Hematology
Yale Cancer Center/Smilow Cancer Hospital